We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$9.83B
AUM Growth
+$1.07B
Cap. Flow
-$195M
Cap. Flow %
-1.98%
Top 10 Hldgs %
25.87%
Holding
1,420
New
446
Increased
141
Reduced
120
Closed
281

Top Buys

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$63.2M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
GSK icon
GSK
GSK
+$50.8M
4
INFY icon
Infosys
INFY
+$49.3M
5
APH icon
Amphenol
APH
+$46M

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$61.3M
2
NTRS icon
Northern Trust
NTRS
+$59.7M
3
NVDA icon
NVIDIA
NVDA
+$58M
4
CACC icon
Credit Acceptance
CACC
+$53.9M
5
BHP icon
BHP
BHP
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 9.1%
2 Healthcare 3.88%
3 Consumer Staples 2.93%
4 Energy 2.82%
5 Financials 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALUR.WS
901
DELISTED
Allurion Technologies Warrants
ALUR.WS
$80.5K ﹤0.01%
319,499
+89,812
+39% +$27.1K
FISV
902
CALL
Fiserv Inc
FISV
$27.9B
$79.9K ﹤0.01%
500
CRBU icon
903
Caribou Biosciences
CRBU
$158M
$78.2K ﹤0.01%
15,207
BKKT.WS icon
904
Bakkt Inc Warrants
BKKT.WS
$286K
$77.4K ﹤0.01%
584,399
-16,068
-3% -$3.1K
PGEN icon
905
Precigen
PGEN
$1.93B
$77.2K ﹤0.01%
53,230
AEON icon
906
AEON Biopharma
AEON
$11.5M
$76.7K ﹤0.01%
+92
New +$66.6K
CLOER
907
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$76.3K ﹤0.01%
620,000
SATLW icon
908
Satellogic Inc Warrant
SATLW
$34.1M
$76K ﹤0.01%
722,764
LSBPW
909
DELISTED
LakeShore Biopharma Warrants
LSBPW
$75.4K ﹤0.01%
1,052,461
PETWW
910
DELISTED
Wag! Group Co Warrant
PETWW
$75K ﹤0.01%
500,000
JD icon
911
PUT
JD.com
JD
$41.8B
$74K ﹤0.01%
2,700
BARK.WS
912
DELISTED
BARK Inc Warrants
BARK.WS
$73.3K ﹤0.01%
2,396,323
LFLYW
913
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$72.2K ﹤0.01%
2,329,972
UHGWW
914
DELISTED
United Homes Group Warrant
UHGWW
$72K ﹤0.01%
73,510
CSLMR
915
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$72K ﹤0.01%
400,000
VALE icon
916
Vale
VALE
$62.9B
$71.9K ﹤0.01%
+5,901
New +$79.7K
ADNWW
917
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$70.4K ﹤0.01%
3,158,425
DAVE icon
918
Dave Inc
DAVE
$5.16B
$70.3K ﹤0.01%
+1,893
New +$43.6K
CRDF icon
919
Cardiff Oncology
CRDF
$65M
$70K ﹤0.01%
+13,101
New +$34.8K
FHLTW
920
DELISTED
Future Health ESG Corp. Warrant
FHLTW
$69.3K ﹤0.01%
990,000
LANV.WS
921
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$69.1K ﹤0.01%
1,384,445
GOSS icon
922
Gossamer Bio
GOSS
$97.5M
$69K ﹤0.01%
+58,445
New +$64.3K
NNBR icon
923
NN Inc
NNBR
$273M
$67.8K ﹤0.01%
+14,297
New +$65.7K
TRIS.WS
924
DELISTED
Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRIS.WS
$67.8K ﹤0.01%
975,000
MAPSW
925
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$66.2K ﹤0.01%
1,018,689

Similar funds

LMR Partners's Q1 2024 Portfolio in Review

As of Q1 2024, LMR Partners held 1,420 positions worth $9.83B, up 12% from $8.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

LMR Partners's Q1 2024 filing shows 446 new, 141 increased, 120 reduced and 281 closed positions. Its largest new stake was GSK: 1,232,283 shares worth $52.8M. The largest sale was Truist Financial, an estimated $61.3M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Consumer Staples.

  • LMR Partners's largest Q1 2024 buy was GSK: 1,232,283 shares worth $52.8M.
  • LMR Partners added most to HDFC Bank in Q1 2024, an estimated $63.2M increase.
  • LMR Partners's biggest Q1 2024 reduction was Credit Acceptance, cutting an estimated $53.9M.
  • LMR Partners fully exited Truist Financial in Q1 2024, selling an estimated $61.3M.
  • LMR Partners's ten largest holdings make up 26% of its $9.83B portfolio in Q1 2024.
  • LMR Partners opened 446 new positions and closed 281 in Q1 2024.
  • LMR Partners's portfolio value rose 12% quarter-over-quarter to $9.83B.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.